Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ionis Pharmaceuticals (IONS)

Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Corcept Therapeutics Stock Surges 61% in 2024: A Must Buy?

Corcept Therapeutics Incorporated CORT has been having a fabulous 2024, with its share price increasing 60.5% year to date as of Nov. 5, 2024.This company engages in the discovery and development of drugs...

CORT : 55.92 (-0.30%)
COLL : 30.41 (+1.37%)
IONS : 35.19 (+3.68%)
Ionis Pharmaceuticals: Q3 Earnings Snapshot

Ionis Pharmaceuticals: Q3 Earnings Snapshot

IONS : 35.19 (+3.68%)
New Higher Dose Nusinersen Efficacy and Safety Data Presented at World Muscle Society Congress, Highlight Potential to Maximize Benefit of Nusinersen in SMA

IONS : 35.19 (+3.68%)
BIIB : 158.01 (+1.29%)
IONS' Rare Neurology Disorder Candidate Gets FDA's Fast Track Tag

Ionis Pharmaceuticals, Inc. IONS announced that the FDA has granted a Fast Track designation to its investigational RNA-targeted therapy zilganersen for treating Alexander disease (AxD), an ultra-rare...

KRYS : 183.51 (+0.67%)
FULC : 2.97 (-0.67%)
IONS : 35.19 (+3.68%)
ANIP : 55.30 (-1.00%)
Ionis Pharmaceuticals: Q2 Earnings Snapshot

Ionis Pharmaceuticals: Q2 Earnings Snapshot

IONS : 35.19 (+3.68%)
Ionis Pharmaceuticals: Q1 Earnings Snapshot

Ionis Pharmaceuticals: Q1 Earnings Snapshot

IONS : 35.19 (+3.68%)
Ionis Pharmaceuticals: Q4 Earnings Snapshot

Ionis Pharmaceuticals: Q4 Earnings Snapshot

IONS : 35.19 (+3.68%)
Markets Today: Stock Index Futures Add to Record Highs on U.S. Economic Optimism

Morning Markets March E-Mini S&P 500 futures (ESH24 ) are up +0.35%, and March Nasdaq 100 E-Mini futures (NQH24 ) are up +0.57%, both at new all-time nearest-futures highs. Stock index futures this morning...

ESZ24 : 5,966.00 (-0.08%)
NQZ24 : 20,791.00 (-0.18%)
SMCI : 30.73 (+3.47%)
ZS : 209.00 (+0.82%)
M : 15.31 (+1.59%)
S : 28.25 (+0.43%)
IONS : 35.19 (+3.68%)
NS : 21.96 (-1.83%)
NET : 104.59 (+0.34%)
ADM : 53.15 (-0.08%)
BA : 143.35 (-0.04%)
RILY : 4.86 (+0.62%)
Ionis Pharmaceuticals: Q3 Earnings Snapshot

Ionis Pharmaceuticals: Q3 Earnings Snapshot

IONS : 35.19 (+3.68%)
Ionis to hold third quarter 2023 financial results webcast

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Thursday, November 2nd at 11:30 a.m. Eastern...

IONS : 35.19 (+3.68%)

Barchart Exclusives

Should You Buy, Sell, or Skip Semtech Stock Ahead of Q3 Earnings?
Semtech is a semiconductor company that has recently trailed broader markets. Can the tech stock benefit from the AI megatrend? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar